SEC Form 4 · accession 0001127602-19-008802

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 26, 2019

Accepted (ET)

Feb 28, 2019 · 9:43 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 26, 2019	S	1,000	$139.64	D	301,359	D
Common Stock	Feb 26, 2019	S	70	$139.645	D	301,289	D
Common Stock	Feb 26, 2019	S	200	$139.65	D	301,089	D
Common Stock	Feb 26, 2019	S	30	$139.66	D	301,059	D
Common Stock	Feb 26, 2019	S	1	$139.665	D	301,058	D
Common Stock	Feb 26, 2019	S	430	$139.67	D	300,628	D
Common Stock	Feb 26, 2019	S	170	$139.675	D	300,458	D
Common Stock	Feb 26, 2019	S	400	$139.68	D	300,058	D
Common Stock	Feb 26, 2019	S	2	$139.695	D	300,056	D
Common Stock	Feb 26, 2019	S	59	$139.70	D	299,997	D
Common Stock	Feb 26, 2019	S	30	$139.715	D	299,967	D
Common Stock	Feb 26, 2019	S	240	$139.72	D	299,727	D
Common Stock	Feb 26, 2019	S	76	$139.73	D	299,651	D
Common Stock	Feb 26, 2019	S	410	$139.74	D	299,241	D
Common Stock	Feb 26, 2019	S	1	$139.745	D	299,240	D
Common Stock	Feb 26, 2019	S	200	$139.75	D	299,040	D
Common Stock	Feb 26, 2019	S	300	$139.76	D	298,740	D
Common Stock	Feb 26, 2019	S	100	$139.77	D	298,640	D
Common Stock	Feb 26, 2019	S	94	$139.78	D	298,546	D
Common Stock	Feb 26, 2019	S	500	$139.80	D	298,046	D
Common Stock	Feb 26, 2019	S	99	$139.805	D	297,947	D
Common Stock	Feb 26, 2019	S	560	$139.81	D	297,387	D
Common Stock	Feb 26, 2019	S	100	$139.82	D	297,287	D

No Table II lines on this filing.